Progressive systemic sclerosis is characterised by an excessive accumulation of collagen in various tissues, including skin, subcutaneous tissues, lungs, and other internal organs."
Fibrosis of the affected organs seems to be at least partly due to excessive collagen production by fibroblastic cells, a phenomenon that can be shown in cultured fibroblasts both as increased amounts of mRNA for collagen types I and III and as increased accumulation of polypeptides containing hydroxyproline.5 6 Also the activities of prolyl and lysyl hydroxylases, two enzymes participating in collagen biosynthesis, are higher than in control cells.7 Raised type III/type I collagen ratios have been found in the skin and kidneys of patients with progressive systemic sclerosis. 9 During recent years several methods have been introduced that allow assessment of the activity of connective tissue metabolism in patients by analysing blood samples. These are based on the measurement of some of the enzymes of collagen biosynthesis, fragments of procollagen or collagen molecules, or known parts of non-collagenous basement membrane proteins.'""2 The method most studied has been the assay for the amino terminal propeptide of type III procollagen. This antigen is partially set free during the synthesis of collagen, before the collagen molecules assemble to form fibrils, and partially derived from the remodelling and turnover of such type III collagen molecules that have retained this propeptide while already on the surface of type III collagen fibres. '3 In normal serum most of the propeptide antigenicity is due to quite small degradation products, which, however, react with a lower affinity with most antisera.
It has been suggested that the serum concentration of the antigens related to the amino terminal propeptide of type III procollagen is increased in progressive systemic sclerosis and that this increase is detected best by an assay that preferentially measures the small degradation products. '4 The aim of the present study was to find out how the serum concentration of the amino terminal propeptide is related to the clinical features and to other laboratory indices of progressive systemic sclerosis. In addition, we wanted to see whether this disease, which is known to affect small arteries and capillaries, influences the serum concentrations of two basement membrane protein antigens, the 7S domain of type IV collagen and the fragment P1 of laminin. Finally, the activity of galactosylhydroxylysyl glucosyltranferase (GGT), an enzyme participating in the biosynthesis of collagen and known to preserve its activity in serum, was studied in progressive systemic sclerosis. The radioimmunoassays for two basement membrane antigens-the 7S domain of human type IV collagen and the fragment P1 of human laminin-have been described previously. '9 The amino terminal propeptide of type III procollagen was measured by two different commercial radioimmunoassays: one, termed here PIIINP, detects both larger antigen forms, including the intact aminopropeptide, and small degradation products of the antigen, the latter with a lower affinity, however,20 21 whereas the other, termed here PIIINP-Fab, preferentially measures the degradation products.22 Both of these PIIINP assays were carried out with kits from Behringwerke, Marburg, FRG. The results in the laminin P1 assay and in the PIIINP assay were calculated with a 50% intercept method'0 because of absence of parallelism between inhibition curves of serum samples and of reference inhibitors.
Patients and methods

PATIENTS
REFERENCE INTERVALS
The mean (SD) of serum GGT in 77 healthy adults was 0-43 (0 07) U/1, the upper normal limit (mean +2 SD) thus being 0-57 U/1. For the PIIINP antibody assay, samples of 35 healthy volunteers gave a value of 8-4 (1-6) [g/l; 12 ,ug/l was used as upper limit of the reference interval. The corresponding values for the PIIINP-Fab assay were 39 (12) [ig/l and 63 ,ug/l respectively, and for laminin P1 26 (5 5) [tg/l and 37 tig/l respectively. For the 7S domain of type IV collagen, concentrations exceeding 10 utg/l were considered pathological. 9 It has been shown earlier that in adults there is no variation with age or sex in these values. 16 The presence or absence of Sjogren's syndrome did not explain the serum indices either. Table  3 shows the clinical characteristics which were found to influence the serum markers stu4ied.
Impairment of renal function was associated with increased serum concentrations of PIIINPFab. Two of these patients have died and were found to have typical sclerodermatous kidneys: their PIIINP-Fab values were 95 and 72 pg/l, whereas the PIIINP values measured with the antibody assay were at the upper limit of the reference range. Table 4 gives a more detailed analysis of the relation between kidney function and PIIINP-Fab. D-Penicillamine treatment clearly does not explain the proteinuria or the decreased creatinine clearance, which were found in about one fifth of the patients. The mean serum concentration of fragmented PIIINP, as measured by the PIIINP-Fab assay, was significantly higher in patients with proteinuria than in those without it. A similar, although not statistically significant, association was noted between PIIINP-EVab results and impaired creatinine clearance (not shown). Of the other extracellular matrix markers, laminin P1 tended to increase with impaired kidney function, though the difference did not reach significance.
PIIINP was related to the presence of Raynaud's phenomenon in hands. Again, the laminin P1 values tended to differ between the groups, but the difference was not significant.
The presence of arthritis was related to increased serum concentrations of PIIINP and PIIINP-Fab and an increased activity of the glucosyltransferase.
The patients were divided into three groups according to the course of their disease (acute, subacute, chronic). There were significant differences between these groups for the lamInin P1 and PIIINP-Fab-patients with an acute disease having the highest and those with a chronic course of disease having the lowest mean values (fig 2) . Table 5 shows the correlations found between the different markers of collagen and basement membrane metabolism. There was a highly statistically different. In B the difference between groups I and 2 is almost significant (p<0 05), that between 2 and 3 significant (p<001), and that between I and 3 highly significant (p<0001). In C the difference between groups I and 2 is not significant, but the differences between group 3 and either ofthe other groups are almost signiftcant (p<0 05). 
CORRELATIONS BETWEEN THE DIFFERENT INDICATORS OF COLLAGEN AND BASEMENT MEMBRANE METABOLISM
Discussion
The aim of this study was to find out whether the development of fibrosis in progressive systemic sclerosis is accompanied by such changes in collagen and basement membrane related metabolites in serum that they could be assumed to aid in the follow up of the disease process. Five different methods were evaluated in a cross sectional investigation of 84 patients with progressive systemic sclerosis. A number of assays have been described for assessing changes in connective tissue proteins from serum samples.0l13 Most of these are based on the immunological detection of defined parts of (pro)collagens or other matrix molecules. Four such assays were used here: two different methods for the amino terminal propeptide of type III procollagen-one mainly measuring the authentic propeptide and an antigen form larger than this (the PIIINP assay with intact antibodies) and the other mainly detecting small degradation products of the propeptide (the PIIINP-Fab assay with Fab fragments of antibodies), a method for the 7S domain of type IV collagen, and a method for the P1 fragment of laminin. In addition, the activity of GGT, an enzyme participating in the biosynthesis of collagen, was measured.
Raised serum concentrations of the amino terminal propeptide of type III procollagen have earlier been found in patients with systemic sclerosis.14 [25] [26] [27] The results of our study indicate that the increases in both the larger forms of PIIINP, as measured by the antibody PIIINP assay, and in the degradation products of this antigen, as detected by the PIIINP-Fab assay, occur during active phases of the disease, as indicated by the presence of immune complexes and antinuclear antibodies. Active arthritis, in particular, was associated with increased PIIINP concentrations; a similar finding has previously been made in rheumatoid arthritis. There were no indications of either liver or bone marrow being affected in any of the patients studied here.
Small blood vessels are typically affected in progressive systemic sclerosis. One of the aims of this study was to find out whether this microcirculatory disorder is reflected in the serum concentration of the basement membrane derived antigens. This was not the case, however, as the concentration of the 7S collagen antigen was hardly changed. The serum antigen detected by this assay is very large in size,'9 probably representing almost intact type IV collagen molecules, and seems to be derived mostly from tissues with sinusoidal blood vessels, like liver or bone marrow, rather than from tissues with intact capillary walls.'0 13 The concentration of the laminin P1 antigen in serum was more affected by the disease, its behaviour in progressive systemic sclerosis resembling that of PIIINP and PIIINP-Fab. During the preparation of this study another group reported slightly raised mean concentrations of the laminin P1 antigen and the NC1 antigen of type IV collagen in progressive systemic sclerosis30; none of these correlated with the activity of the disease, however. 
